Verified earnings results
4D Molecular Therapeutics Q2 2026 Earnings Results
Direct answer
4D Molecular Therapeutics reported Q2 2026 results on August 13, 2026.
Revenue was 3,781,000. EPS missed the estimate by 0.29%.
The result is verified against Verified earnings source.
Verified earnings source
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 13, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -1.037
- Reported EPS
- -1.04
- Revenue
- 3,781,000
- EPS surprise
- EPS missed the estimate by 0.29%.
Explore related company data
Read the frequently asked questions.
When did 4D Molecular Therapeutics report Q2 2026 earnings?
4D Molecular Therapeutics reported on August 13, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for 4D Molecular Therapeutics?
The verified record provides an EPS estimate of -1.037.
Has 4D Molecular Therapeutics reported the Q2 2026 result?
Revenue was 3,781,000. EPS missed the estimate by 0.29%.
Which source supports this 4D Molecular Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.